Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation

Long-term survival and outcome were determined for 80 patients with immunoglobulin light chain (AL) amyloidosis treated with high-dose melphalan and stem cell transplantation (HDM/SCT) more than 10 years ago. Seventeen (21%) patients died within the first year of treatment, of treatment-related comp...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sanchorawala, Vaishali, Skinner, Martha, Quillen, Karen, Finn, Kathleen T., Doros, Gheorghe, Seldin, David C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2007
Soggetti:
Clinical Trials and Observations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2077307/
https://ncbi.nlm.nih.gov/pubmed/17673601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-07-099481
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi